MedPath

The effect of basil extract in insomnia .

Phase 2
Conditions
Major deprassion + Insomnia.
Insomnia
Registration Number
IRCT20180603039967N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

The patients betwwen 18 to 65 years old suffering from major deppresion
Getting at least the score 12 out of 28 of the insomnia severity index questionnaire

Exclusion Criteria

Taking any sedative medication in last month
Sufferng from significant medical diseases like cardiopulmonary failure, cancer, vascular disease, rheumatologic diseases, history of seizure, thyroid disease, ...
Taking anticoagulant or antiplatelet medications like warfarin, aspirin ,...
Opioid and alcohol addiction
Pregnancy and lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beck depression inventory score /Insomnia Severity Index score (ISI) / Pittsburgh Sleep Quality Index score(PSQI). Timepoint: Filling the questionnaires before starting the intervention and 4 week after taking drug. Method of measurement: Beck depression inventory /Insomnia Severity Index (ISI) / Pittsburgh Sleep Quality Index (PSQI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath